TKR patellar resurfacing, CAR-Ts, tranexamic acid, and patient messaging

TT HealthWatch - June 26, 2026
Elizabeth Tracey and Dr. Richard Lange

This week's topics include patellar resurfacing with TKR, long-term outcome for CAR-Ts, tranexamic acid in routine surgery, and patient messaging trends.

Program notes:

0:40 Electronic patient messaging

1:40 Not baked into the usual workday

2:40 Managing patient expectations

3:33 Tranexamic acid in noncardiac surgery

4:33 Almost 9,000 patients enrolled

5:30 Does it increase VTE?

6:31 UK attempted 10 years ago

7:00 CAR-T cell outcomes 10 years later

8:01 Somewhere between 10-15% would have relapsed

9:03 Patellar resurfacing in total knee replacement

10:00 More QALYs than those without resurfacing

11:00 More people alive in the knee resurfacing

12:34 End

Next
Next

Brain development in kids, multimorbidity, childhood obesity, and prehabilitation